Veliks Janis, Videja Melita, Kinens Artis, Bobrovs Raitis, Priede Martins, Kuka Janis
Latvian Institute of Organic Synthesis, Aizkraukles 21, Riga LV-1006, Latvia.
Ri̅ga Stradiņš University, Faculty of Pharmacy, Dzirciema Str. 16, Riga LV-1007, Latvia.
ACS Med Chem Lett. 2020 Sep 11;11(11):2146-2150. doi: 10.1021/acsmedchemlett.0c00220. eCollection 2020 Nov 12.
Investigation of the -fluorine effect on the hydrolysis rate of diethyl 2-fluorocyclopropane-1,1-dicarboxylate provides synthetic access to both diastereomers of the fluorocyclopropyl analog of cabozantinib, a c-Met and VEGFR-2 inhibitor used as a first-line treatment for thyroid cancer and as a second-line treatment for renal cell carcinoma. Despite some known potent examples, there are only a few drug molecules that contain fluorocyclopropane moieties. Herein, we present a case study in which the monofluoro analog of a known cyclopropane-containing drug molecule displays an improved profile compared to the parent nonfluorinated structure. The fluorocyclopropane moiety may offer valuable fine-tuning options for lead optimization in drug discovery.
研究氟对2-氟环丙烷-1,1-二羧酸二乙酯水解速率的影响,为合成卡博替尼的氟环丙基类似物的两种非对映异构体提供了途径。卡博替尼是一种c-Met和VEGFR-2抑制剂,用作甲状腺癌的一线治疗药物和肾细胞癌的二线治疗药物。尽管有一些已知的强效例子,但含有氟环丙烷部分的药物分子却很少。在此,我们展示了一个案例研究,其中一种已知含环丙烷药物分子的单氟类似物与母体非氟化结构相比,显示出更好的特性。氟环丙烷部分可能为药物发现中的先导优化提供有价值的微调选项。